A tropane-based ibogaine analog rescues folding-deficient SERT and DAT
Preprint
Abstract
Missense mutations that give rise to protein misfolding are rare, but collectively, defective protein folding diseases are consequential. Folding deficiencies are amenable to pharmacological correction (pharmacochaperoning), but the underlying mechanisms remain enigmatic. Ibogaine and its active metabolite noribogaine correct folding defects in the dopamine transporter (DAT), but they rescue only a very limited number of folding-deficient DAT mutants, which give rise to infantile Parkinsonism and dystonia. Herein, a series of analogs was generated by reconfiguring the complex ibogaine ring system and exploring the structural requirements for binding to wild type transporters, and for rescuing two equivalent synthetic folding-deficient mutants, SERT-PG 601,602 AA and DAT-PG 584,585 AA. The most active tropane-based analog ( 9b ) was also an effective pharmacochaperone in vivo , in Drosophila harboring DAT-PG 584,585 AA and rescued six out of 13 disease-associated human DAT mutants in vitro. Hence, a novel lead pharmacochaperone has been identified that demonstrates medication development potential for patients harboring DAT mutants.Keywords
All Related Versions
- Published version: ACS Pharmacology & Translational Science, 4 (2), 503.
This publication has 44 references indexed in Scilit:
- How to rescue misfolded SERT, DAT and NET: targeting conformational intermediates with atypical inhibitors and partial releasersBiochemical Society Transactions, 2019
- Serotonin transporter–ibogaine complexes illuminate mechanisms of inhibition and transportNature, 2019
- A label-free approach to detect ligand binding to cell surface proteins in real timeeLife, 2018
- Pharmacochaperoning in a Drosophila model system rescues human dopamine transporter variants associated with infantile/juvenile parkinsonismJournal of Biological Chemistry, 2017
- Conformational state interactions provide clues to the pharmacochaperone potential of serotonin transporter partial substratesJournal of Biological Chemistry, 2017
- Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomesThe American Journal of Drug and Alcohol Abuse, 2017
- Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous CellsJournal of Biological Chemistry, 2016
- Defining the blanks – Pharmacochaperoning of SLC6 transporters and ABC transportersPharmacological Research, 2014
- The Mechanistic Basis for Noncompetitive Ibogaine Inhibition of Serotonin and Dopamine TransportersJournal of Biological Chemistry, 2012
- Ibogaine effects on sweet preference and amphetamine induced locomotion: implications for drug addictionBehavioural Brain Research, 1997